Rize Oncology Inc.
RIZE
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 20.28% | -6.31% | -17.68% | -8.13% | 0.15% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -39.16% | -32.06% | 4,786.67% | -96.83% | -48.47% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 17.36% | -8.02% | -11.94% | -11.10% | -2.92% |
|
|
|||||
| Total Current Assets | 17.36% | -8.02% | -11.94% | -11.10% | -2.92% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 17.36% | -8.02% | -11.94% | -11.10% | -2.92% |
|
|
|||||
| Total Accounts Payable | 171.09% | 26.72% | -57.74% | 73.73% | 4.29% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 182.65% | 26.72% | -57.74% | 42.23% | 27.39% |
|
|
|||||
| Total Current Liabilities | 182.65% | 26.72% | -57.74% | 42.23% | 27.39% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 182.65% | 26.72% | -57.74% | 42.23% | 27.39% |
|
|
|||||
| Common Stock & APIC | 0.01% | 0.34% | 0.03% | 0.06% | 4.38% |
| Retained Earnings | -3.65% | -2.84% | -2.44% | -3.37% | -7.97% |
| Treasury Stock & Other | 142.33% | 6.34% | -5.94% | -18.30% | 10.72% |
| Total Common Equity | 12.44% | -8.77% | -9.84% | -12.61% | -3.56% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 12.44% | -8.77% | -9.84% | -12.61% | -3.56% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 12.44% | -8.77% | -9.84% | -12.61% | -3.56% |
|
|
|||||